Leading tech company and healthcare provider SteadyMD has announced a $25 million Series B capital raise to enhance the company’s platform. Lux Capital led the round, with Partner Deena Shakir joining the SteadyMD Board of Directors. The new capital comes after five years of strong growth within SteadyMD’s proven direct-to-consumer primary care offering.
- Since its Series A round in early 2020, led by Pelion Venture Partners and NEXT VENTŪRES, SteadyMD has capitalized on the technology and clinicians behind the success of its consumer business. It aims to help digital health companies and employers do the same for their patients and employees. SteadyMD currently works with leading employers and online-first companies delivering primary care, behavioral health, digital pharmacy, medical device, at-home lab, and other telehealth services.
- Yarone Goren, SteadyMD Co-founder & COO, said “Our success on the front lines now enables us to work behind the scenes for companies with like-minded missions to design quality telehealth solutions,”, adding “Between clinician management and staffing, predicting patient demand, patient-provider matching, legal and regulatory issues, and the technology infrastructure that goes into a best-in-class telehealth operation, we’re helping companies deliver the highest quality healthcare where patients are — online.”
- In addition to Lux Capital, Sound Ventures, and Acrew Capital, several prominent healthcare executives and investment leaders participated in the Series B round, including Anne Wojcicki (co-founder of 23andMe) and Draper Associates.